Patients & Caregivers

An elderly couple embrace

Exploring new ways to improve and extend people's lives

Novartis works with the patient community around the world to discover new ways to improve and extend people’s lives. Our significant investment in research and development underpins our commitment to using science-based innovation to address some of society's most challenging healthcare issues. Only by working together can we improve outcomes for patients and change the practice of medicine.

  • 40+

    Patient Organizations representing

  • 200M

    Patients contributed to its development

  • 110 000

    Novartis associates own it as an aspiration

The four pillars of our Commitment

  • Icon of a handshake

    Respecting and understanding the patient community perspective

  • Icon of a globe

    Expanding access to our medicines

  • Icon of a stethoscope

    Conducting responsible clinical trials

  • Icon of a magnifying glass

    Recognizing the importance of transparency and reporting

Our Focus

Novartis appoints Marc Boutin as Global Head of Patient Engagement & Advocacy

Learn More

Adult hands holding a baby's feet
Opens a Dialog

Our Commitment to Patients and Caregivers

We recognize the importance of patients and caregivers understanding what they can expect from Novartis.

Learn More

Transmission electron microscopic image of an isolate from a case of COVID-19

Patients and Caregivers COVID-19 Information

Novartis is working to ensure supply of our medicines, enhance virtual services, protect the integrity of clinical trials and support patient organizations during the COVID-19 pandemic.

Learn More

A doctor talking to a nurse

Disclosure of Payments to Healthcare Professionals

Novartis publishes payments and other ‘transfers of value’ to Healthcare Professionals to increase transparency and build trust. Many countries disclose 2020 payments in June 2021. 

Learn More

The Commitment to Patients and Caregivers – Reporting 2020 progress

  • 67% Early research programs

    in general medicines obtained patient insights before first in human trials (healthy volunteers). Piloted patient panels for five Proof of Concept indications

  • 9 998 Patients reached through managed access programs

    94% requests approved for 64 compounds in 82 countries - providing pre-approval access to Novartis medicines

  • 44 Clinical development programs

    comprising 69 clinical trials, had a patient engagement component to obtain the patient perspective on the design and / or conduct of clinical trials

  • 90 Clinical trials

    included Patient Reported Outcomes (PRO) conducted in 57 countries

  • 95 Simplified summaries

    from Phase 1-4 clinical trials sent to investigators to share with 14,668 trial participants and posted on novartisclinicaltrials.com

  • 66M Patients

    reached through Access programs

Novartis Investigational Medicines
  • Researchers in lab

    About clinical trials

    Clinical trials are scientific studies conducted to find better ways to prevent, screen for, diagnose or treat disease.

    Learn More About clinical trials
  • A doctor speaks with a patient

    Participating in Novartis clinical trials

    Novartis is currently conducting clinical trials around the world for a number of diseases.

    Learn More Participating in Novartis clinical trials
  • Two medication bottles

    Managed Access programs

    Novartis Managed Access makes investigational or unapproved treatments available to eligible patients with serious or life-threatening diseases. Your physician may request access.

    Learn More Managed Access programs
  • Portrait of a patient and a healthcare professional

    Diversity

    Diversity in clinical trials is integral to who we are at Novartis and we are working hard to improve both the diversity of patients enrolled in our clinical research and the investigators involved in our trials.

    Learn More (PDF 0.2 MB) Diversity
Collaborations with Patient Organizations
A woman, accompanied by her caregiver, shares her experiences with a doctor.

Sound up for lung cancer research

Global Oncology Patient Insights Panels (GOPIPs) are giving patients and advocates a critical voice in advancing lung cancer trials.

Read More

Nurse checking patient’s blood pressure

Novartis ranks #4 in PatientView’s 2019 corporate reputation survey of patient organizations worldwide

The Corporate Reputation of Pharma 2019 global report reflects the findings of a survey conducted by PatientView with patient organizations worldwide.

Learn More

Vas Narasimhan sat discussing patient engagement with Marc Boutin, CEO of the National Health Council.
Opens a Dialog

Patient Organizations and Novartis

We collaborate with patient organizations and healthcare organizations globally in the disease areas for which we provide or are developing medicines. This collaboration is based on values of mutual respect, trust and transparency.

Learn More

Two men handshaking

External Funding

Novartis may provide funding to legitimate organizations to support its mission to discover new ways to improve and extend people's lives, advancing scientific and medical knowledge, and supporting the communities where Novartis Associates live and work.

Learn More

Patient Perspectives
A mother and daughter hugging.

We commit to actively seeking out and listening to insights from the patient community. Visit our YouTube channel to watch our Patient & Caregiver stories and learn more about our resources.

Watch the Videos

Our Focus Areas

For questions about Novartis, medical inquiries about our products and or information about services, we recommend you contact the Novartis office in your country. If you’re seeking a global list of products, visit our Global Product Portfolio.